Company · NSPR
InspireMD Inc.
Name as listed on its exchange; filed with the SEC as InspireMD, Inc.
Nasdaq's symbol directory lists NSPR on Nasdaq as “InspireMD Inc. - Common Stock”.
In the 12 months to Nov 19, 2026: insiders bought on 5 occasions ($455K); 4 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Paul Stuka bought $200K
- Gary S. Roubin bought $100K
- Michael A. Lawless, Chief Financial Officer bought $75K
- Michael Berman bought $50K
- Marvin Slosman, CEO and President bought $30K
Every trade (5)
- BUYPaul Stuka bought $200K
- BUYGary S. Roubin bought $100K
- BUYMichael A. Lawless, Chief Financial Officer bought $75K
- BUYMichael Berman bought $50K
- BUYMarvin Slosman, CEO and President bought $30K
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Entry into a material definitive agreement; Other events Nov 16, 2026
- Results of operations and financial condition; Other events Nov 12, 2026
- Regulation FD disclosure; Other events Nov 12, 2026
- Entry into a material definitive agreement; Unregistered sales of equity securities; Regulation FD disclosure Sep 21, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.